(Q34837255)

4 August 2017

1 reference

title

Fibroblast growth factors in cancer: therapeutic possibilities (English)

1 reference

4 August 2017

Michael Jeffers

1

1 reference

4 August 2017

William J LaRochelle

series ordinal

2

1 reference

4 August 2017

Henri S Lichenstein

series ordinal

3

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Expert Opinion on Therapeutic Targets

4 August 2017

published in

1 reference

4 August 2017

volume

6

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

469-482

1 reference

Fibroblast growth factors

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Fibroblast growth factors, their receptors and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Fibroblast growth factors as multifunctional signaling factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Identification of Sef, a novel modulator of FGF signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

An acidic fibroblast growth factor-like factor secreted into the brain cell culture medium upregulates apoE synthesis, HDL secretion and cholesterol metabolism in rat astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

FGF7/KGF triggers cell transformation and invasion on immortalised human prostatic epithelial PNT1A cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Fibroblast growth factor 3 is tumorigenic for mouse mammary cells orthotopically implanted in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Expression of basic fibroblast growth factor is associated with resistance to cisplatin in a human bladder cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Expression of the FGFR1 gene in human breast-carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Role of fibroblast growth factor receptor signaling in prostate cancer cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Smart drugs: tyrosine kinase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Chemical engineering of cell penetrating antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Improving the efficacy of antibody-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Antibody-targeted immunotherapy for treatment of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Recombinant immunotoxins in targeted cancer cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Inhibition of growth factor mitogenicity and growth of tumor cell xenografts by a sulfonated distamycin A derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Receptor- and heparin-binding domains of basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Signal transduction pathway targets for anticancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Basic fibroblast growth factor (bFGF)-induced cell death is mediated through a caspase-dependent and p53-independent cell death receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Human primitive neuroectodermal tumour cells behave as multipotent neural precursors in response to FGF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

bFGF induces differentiation and death of olfactory neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Basic fibroblast growth factor-Pseudomonas exotoxin chimeric proteins; comparison with acidic fibroblast growth factor-Pseudomonas exotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Inhibition of cell growth by a fused protein of human ribonuclease 1 and human basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Targeting of suicide gene delivery in pancreatic cancer cells via FGF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

New strategies in the treatment and prophylaxis of chemo- and radiotherapy-induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Effective prevention of thrombocytopenia in mice using adenovirus-mediated transfer of HST-1 (FGF-4) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

Basic fibroblast growth factor infusion increases tumour vascularity, blood flow and chemotherapy uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

The human FGF gene family: chromosome location and phylogenetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.6.4.469

21 January 2018

Identifiers

DOI

10.1517/14728222.6.4.469

1 reference

4 August 2017

1 reference